Literature DB >> 826527

Mechanism for irreversible self-deactivation of prostaglandin synthetase.

R W Egan, J Paxton, F A Kuehl.   

Abstract

It has been shown that prostaglandin (PG) cyclooxygenase is irreversibly self-deactivated during the oxygenation of arachidonic acid (Smith, W. L., and Lands, W.E.M. (1972) Biochemistry II, 3273-3285). Using several experimental approaches and an enzyme preparation which was highly active without artificial stimulation, we have extensively investigated the mechanism of this deactivation process. During the generation of PGH2 from arachidonic acid, oxidizing equivalents were released and the reductive breakdown of PGG2 was found to deactivate the cyclooxygenase. The cyclooxygenase-catalyzed metabolism of both arachidonic acid and PGG2 generated radicals which were scavenged by phenol. Both phenol and methional (scavengers of oxygen-centered radicals) promoted the formation of PGH2 at the expense of PGG2 and increased the initial rate and the extent of reaction prior to deactivation of the cyclooxygenase. Hence, it appears that the cyclooxygenase was irreversibly self-deactivated during the formation of PGH2 from arachidonic acid, due to its oxidation by oxygen-centered radicals formed as a result of the reductive breakdown of the hydroperoxide on PGG2. Some experiments with dithiothereitol and N-ethylmaleimide suggested that the enzyme may contain a disulfide at the active site. A mechanism has been devised which accounts for the self-deactivation phenomenon, the effect of phenol and methional, the disulfide at the active site, and the pathway of substrate oxygenation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826527

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  Rapid inactivation of cyclooxygenase activity after stimulation of intact platelets.

Authors:  E G Lapetina; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

2.  Heneicosapentaenoate (21:5n-3): its incorporation into lipids and its effects on arachidonic acid and eicosanoid synthesis.

Authors:  L N Larsen; K Høvik; J Bremer; K H Holm; F Myhren; B Børretzen
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

Review 3.  Reactive oxygen metabolites and the human myocardium.

Authors:  C J Burrell; D R Blake
Journal:  Br Heart J       Date:  1989-01

Review 4.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

5.  Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.

Authors:  J M Ritter
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

6.  Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.

Authors:  T M McIntyre; G A Zimmerman; K Satoh; S M Prescott
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia.

Authors:  S Nogawa; C Forster; F Zhang; M Nagayama; M E Ross; C Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 8.  Gene therapy for vascular diseases.

Authors:  K K Wu; P Zoldhelyi; J T Willerson; X M Xu; D S Loose-Mitchell; L H Wang
Journal:  Tex Heart Inst J       Date:  1994

9.  Regulation of prostaglandin production by nitric oxide; an in vivo analysis.

Authors:  D Salvemini; S L Settle; J L Masferrer; K Seibert; M G Currie; P Needleman
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

10.  Role of hydrogen peroxide in the neutrophil-mediated release of prostacyclin from cultured endothelial cells.

Authors:  J M Harlan; K S Callahan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.